Neural prostheses are a promising technology in the treatment of lost neural function. However, poor biocompatibility of these devices inhibits the formation of a robust neuro-electrode interface. Several factors including mechanical mismatch between the device and tissue, inflammation at the implantation site, and possible electrical damage contribute to this response. Many researchers are investigating polymeric brain mimetic coatings as a means to improve integration with nervous tissue. Specifically, hydrogels, constructs also employed in tissue engineering, have been explored because of their structural and mechanical similarity to native tissue. However, many hydrogel materials (e.g., poly(ethylene glycol) (PEG)) do not support cell adhesion. In this work, we report a technique to enhance the interface between polymeric brain mimetic coatings and neural tissue using adhesion molecules. In particular, polylysine-modified PEG-based hydrogels were synthesized, characterized and shown to promote neural adhesion using a PC12 cell line. In addition, we examined adhesion behavior of a PEG-co-polymer and found that these materials adhere to electrodes for at least 4 weeks. These results suggest that polylysine-PEG hydrogel biomaterials are biocompatible and can enhance stability of chronic neural interfaces.
Introduction
Neurodegenerative disorders (e.g., Alzheimer's disease, Parkinson's disease) cause substantial loss of neural function, affecting over a million individuals every year [1] . Unfortunately, central nervous system (CNS) neurons do not regenerate following injury [2] . One strategy for treatment has been the use of tissue engineering to enhance nerve regeneration at the injury site; however, these approaches have seen only limited success [3] . Alternatively, researchers have developed neural pros-theses, which restore lost electrical signaling by converting an external signal into an electrical pattern transmitted to cells via microelectrodes [4] . Neural prostheses have had some success, most notably the cochlear implant [5] . However, several challenges, including difficulty in accessing target neuronal tissue [6] and scarring resulting from the host immune response to implantation [7] , have prevented the formation of a robust neuro-electrode interface.
For the last several years, our group [6, 8, 9] and others [10] [11] [12] have examined the possibility of combining tissue-engineering approaches with neural prostheses to create a composite material that promotes integration with target neural tissue. Several biomaterials have been developed as electrode coatings, including conducting polymers [13, 14] , layer-by-layer (LbL) assemblies [15] and polymeric hydrogels [6, 8] . Among these, hydrogel-based coatings have attracted considerable attention because their structural and mechanical properties mimic native brain tissue. Hydrogels are cross-linked, hydrophilic polymeric structures that swell in solution [16] . Specifically, hydrogels have been employed as drug eluting devices (e.g., for neurotrophin delivery) [6, 17, 18] for improving electrode-tissue integration. Unfortunately, many of these drugs (i.e., neurotrophins) have a very short half-life in vivo [19] . Additionally, efficacy is compromised after the supply of drugs is exhausted. Therefore, additional cues will be needed to sustain and improve electrode-tissue integration. In the peripheral nervous system (PNS), regeneration occurs not only because of soluble factors but also because of adhesion molecules (i.e., proteins/peptides that promote neural adhesion) [2] . Further, adhesion molecule-modified hydrogels have been utilized as neural tissue-engineering constructs [20] . Adhesion molecules, thus, are attractive candidates for improving tissue integration with neural biomaterials [21, 22] . These molecules have been previously utilized in combination with conducting polymers [23] as well as with LbL assemblies [15] as neuro-prosthetic coatings, although not with hydrogel systems.
Here, we examined the ability of adhesion molecule-modified hydrogel coatings to promote adhesion to electrode surfaces, thereby enhancing the neuro-electrode interface. Specifically, we investigated poly(ethylene glycol) (PEG)-based hydrogels modified with the non-native adhesion molecule, polylysine (PL). PEG was selected as a hydrogel material because of its non-immunogenic properties [24] whereas PL was selected because of its ability to support neuronal adhesion [25] . PL-modified PEG diacrylate (PEGDA) hydrogels were developed, characterized and investigated for their ability to promote neuronal adhesion. Additionally, recognizing the fact that PEGDA hydrogels do not normally adhere to hydrophobic electrode surfaces; we examined the adhesion of PEG-hydroxyacid co-polymers (e.g., lactide, caprolactone) to electrode surfaces. The addition of hydroxyacids also provides a strategy for biodegradation of the coating, so that it is removed from the electrode surface after the acute immune response to implantation. As proof of concept, poly(ethylene glycol)-poly(caprolactone) diacrylate (PEG-PCL) hydrogels were synthesized and their adhesion to model retinal prosthesis electrodes was characterized. Adhesion molecule-modified hydrogel coatings offer great promise to enhance electrode-host integration. Furthermore, this technique is broadly applicable to any implant material (i.e., stimulating or recording electrodes). Hydrogels can be tuned to mechanically resemble target tissue and to release soluble factors. The addition of adhesion molecules to this system provides a means to combine chemical and mechanical similarities to native tissue.
Materials and Methods

Preparation of Acryl-PEG-Polylysine (Acryl-PEG-PL)
Polylysine was conjugated to acryl-poly(ethylene glycol)-N-hydroxyl succinimide (acryl-PEG-NHS) (Laysan Bio) using standard approaches [26] . Briefly, polylysine (30-70 kDa, Sigma-Aldrich) was dissolved in 50 mM sodium bicarbonate (Sigma-Aldrich) and acryl-PEG-NHS (3.4 kDa, Laysan Bio) was dissolved in DMSO (Sigma-Aldrich) in a 1:2 molar ratio. These solutions were mixed and reacted for approx. 2 h in an ice bath. The resulting sample was then dialyzed (Slide-a-lyzer cassettes, Fisher) overnight and reconcentrated to the original volume in phosphate-buffered saline (PBS) using a centrifugal concentrator (Fisher). For quantification, FITC-labeled poly(L-lysine) (PLL) (30-70 kDa, Sigma-Aldrich) and poly(D-lysine) (PDL) (30-70 kDa, Sigma-Aldrich) in a 1:10 (weight ratio) were used, whereas PDL was utilized for all other experiments. Different concentrations of acryl-PEG-PL were prepared by diluting the above stock solution in PBS.
Preparation and Characterization of Poly(ethylene glycol)-Poly(caprolactone) (PEG-PCL) Co-polymers
Poly(ethylene glycol)-poly(caprolactone) (PEG-PCL) co-polymers were synthesized following Hubbell's method [27] . Briefly, PEG (0.95-1.05 kDa, SigmaAldrich) was azeotropically distilled in anhydrous toluene (Sigma-Aldrich) and reacted with ε-caprolactone (Sigma-Aldrich) (1:2 molar ratio) for approx. 24 h, under an argon blanket at 130 • C in the presence of stannous octanoate (SigmaAldrich) catalyst. PEG-PCL co-polymer was then cooled to ambient temperature, dissolved in anhydrous dichloromethane (Sigma-Aldrich), and slowly added to cold hexane to precipitate the product. PEG-PCL co-polymer was collected using Buchner funnel filtration and vacuum dried overnight. This intermediate was then subjected to azeotropic distillation in anhydrous toluene and dissolved in anhydrous dichloromethane in presence of triethylamine (Sigma-Aldrich) (for HCl neutralization). Acrylation of PEG-PCL was performed by reaction with acryloyl chloride (Sigma-Aldrich) (1:2 molar ratio) in anhydrous dichloromethane (1:4 v/v) added at the rate of approx. 0.20 ml/min. The system temperature was maintained at −20 • C for approx. 3 h and at ambient temperature for another 60 h. Acrylated PEG-PCL was purified by removal of TEA-HCl salt via filtration, removal of the solvent by rotary evaporation, and subsequently dissolution in anhydrous tetrahydrofuran (Sigma-Aldrich). The product was collected via filtration, dissolved in anhydrous dichloromethane, precipitated using cold diethyl ether, filtered and vacuum dried in the presence of P 2 O 5 (Sigma-Aldrich). Characterization of PEG-PCL and acrylated PEG-PCL co-polymers was performed using Fourier transform infrared spectroscopy (Nicolet 6700 FT-IR spectrometer, Thermo Scientific) and nuclear magnetic resonance spectroscopy (NMR Bruker DPX400).
Hydrogel Formation and Quantification of Polylysine Attachment
Poly(ethylene glycol)-diacrylate (PEGDA) (3.4 kDa) was procured from Laysan Bio. PEGDA and PEG-PCL hydrogels were prepared following Hubbell's method [27] . Briefly, PEGDA or PEG-PCL was dissolved in PBS at 22 wt% and supplemented with 1% (v/v) initiator (0.33 g Irgacure 2959 (Ciba) in 1 ml N-vinyl-2-pyrrolidone (Sigma-Aldrich)). Of this hydrogel solution, 60 µl was placed in a 96-well plate and subjected to UV illumination (peak power 11.21 mW/cm 2 , sample distance approx. 9 mm) for approx. 10 min. Acryl-PEG-PL (approx. 30 µl) with initiator was then added to the surface of the PEG-based hydrogel, and the sample was subjected to UV illumination (approx. 10 min) ( Fig. 1 ), conditions which have been shown to be acceptable for protein conjugation [28] . Sham hydrogels, consisting of PEGDA hydrogels to which unconjugated PL (i.e., PL in PBS) and initiator were added, were also formed via photo-polymerization. For PEGDA hydrogels, conjugation efficiency was determined by monitoring the diffusion of unreacted FITC-polylysine over a period of 7 days, against a sham (unconjugated polylysine) and a negative control (no polylysine) using a fluorescent microplate reader (excitation wavelength = 485 nm, emission wavelength = 535 nm). The conjugation efficiencies were evaluated using standard concentrations of polylysine. Data were analyzed using ANOVA and pair-wise comparisons were performed using the Tukey-Kramer HSD test (α = 0.05) via JMP statistical software (Version 7). For PEG-PCL hydrogels, conjugation was confirmed using fluorescence microscopy and compared to PEG-PCL hydrogels with unconjugated FITC-polylysine, as well as PEG-PCL hydrogels with no polylysine.
PC12 Cell Culture
PC12 cells (CRL-1721, ATCC) were cultured using Powdered Ham's F12-K Media (Kaighn's modification) (Sigma-Aldrich) supplemented with 1.5 g/l NaHCO 3 , Figure 1 . Schematic of the conjugation procedure.
12.5% horse serum, 2.5% fetal bovine serum (all Sigma-Aldrich) and 1% penicillin-streptomycin (Invitrogen). Cells were cultured in an incubator at 37 • C and 5% CO 2 . Medium was exchanged every 2-3 days, and cells were sub-cultivated weekly before experimentation.
Quantification of Cell Adhesion Using Calcein-AM Staining
Cell adhesion to modified hydrogel surfaces was quantified using the Live-Dead assay (Invitrogen). Non-fluorescent calcein AM is converted by intracellular esterases to intensely fluorescent calcein in live cells, whereas EthD-1 permeates damaged cell membranes and enhances fluorescence by binding to nucleic acids in dead cells. Polylysine-modified hydrogels were prepared as described previously using PDL. For cell experiments, all solutions were sterile filtered using a 13 mm syringe filter, pore size 0.22 µm (Fisher) prior to gelation. Modified hydrogels were immersed in sterile PBS for 1 week and then subjected to UV illumination overnight (for sterilization). PC12 cells at approx. 2 × 10 4 cells/cm 2 were seeded onto all hydrogel surfaces and the positive control (well plate coated with polylysine). After incubating for approx. 24 h, all surfaces were washed with sterile PBS thoroughly (3 times). Cells were then stained with EthD-1 (1 µM) and calcein-AM (2 µM) prepared in sterile Dulbecco's PBS (D-PBS) (Sigma). Following incubation for approx. 45 min, excess dye was removed using sterile D-PBS (3 times) and fluorescence was observed. To quantify cell adhesion, calcein-AM fluorescence was used since fluorescence intensity is directly proportional to cell number. Background fluorescence from dye entrainment in the hydrogel was subtracted from all measurements by observing hydrogels stained at the same dye concentrations, but with no cells. Images were captured using an Olympus IX71 inverted optical microscope equipped with fluorescence filters at 10× magnification. The fluorescence intensities (a.u.) were normalized to the negative control and compared using ANOVA. Pair-wise comparison was performed using the Tukey-Kramer HSD test (α = 0.05) via JMP statistical software (Version 7). Tests were completed twice, with replicates of 6 in each test.
PEG-PCL Electrode Adhesion
Multielectrode arrays (3 × 5 electrodes) used to investigate adhesion of PEG-PCL hydrogels were generously provided by Dr. Stuart Cogan (EIC Laboratories). The arrays consisted of iridium oxide-coated gold electrodes patterned on polyimide substrates [6] . PEG-PCL hydrogel was formed by depositing approx. 1 µl of the precursor solution onto the electrode array surface and subjecting this bolus to UV photo-polymerization. To evaluate the efficacy of the hydrogel coating, static adhesion of the coating as well as adhesion following electrode insertion was monitored. For electrode insertion, PEG-PCL hydrogel coated electrodes were inserted into a 1 wt% agarose brain tissue phantom and removed immediately. Static integrity of the hydrogel coating over time was evaluated by placing coated electrodes under a 1 wt% agar gel blanket, which physically constrained the hydrogel bolus on the electrode surface, mimicking the effect of tissue. Reflected DIC images for both the tests were collected using an Olympus BX41 reflected optical microscope. Images were converted to grayscale using Adobe Photoshop (Version 10.0).
Results
PL Conjugation to PEG Hydrogels
The extent of PL conjugation to PEG hydrogels was examined using fluorescence microscopy to evaluate FITC-PL-conjugated PEG hydrogels (sample), PEG hydrogels with FITC-PL added but not conjugated to the hydrogel backbone (sham) and PEG-based hydrogels with no PL (negative control). Fluorescence values were normalized to the negative control (no FITC-PL, fluorescence intensity = 1). PL conjugation at different concentrations of acryl-PEG-PL was quantified and in all cases was higher and statistically significant (P < 0.0001 for 1× and 0.01×, P = 0.0056 for 0.1×, ANOVA, Tukey test) for PL-conjugated PEG hydrogels (sample) versus the negative control (Fig. 2) . Unconjugated PL (sham) hydrogels were also evaluated for comparison. Intuitively, unconjugated PL should be released from the hydrogel over time. However, we observed that some PL becomes physically entrapped within the gel matrix and unconjugated PL (sham) hydrogels generally exhibit fluorescence intensity higher and statistically significant (Tukey test) from the negative control. In the case of 0.1× dilution, this value, although higher than negative control was not statistically significant (power = 0.93 < 0.95). Comparing PL-conjugated (sample) and unconjugated (sham) hydrogels, it was observed that fluorescent intensity of sample hydrogels was higher and statistically significant from that of sham hydrogels at all dilutions investigated. Exact concentration values (obtained from a standard curve of known concentrations) are summarized in Table 1 .
PC12 Cell Adhesion on PEG Hydrogels
Cell response to PL-modified PEG hydrogels was assessed using the PC12 cell line, a model for neuronal behavior [29] [30] [31] . PC12 cells convert to a neuronal phenotype after exposure to nerve growth factor (NGF) [31] , including extension of neurites. Because the primary focus of this study was cell adhesion and because neurite extension complicates quantification of cell surface area, NGF was excluded from the cell culture medium. Additionally, because this study focused on proof-of-concept and demonstration of biocompatibility, additional cell types (e.g., astrocytes, microglia) were not investigated. PC12 cell adhesion was quantified using calcein AM staining with fluorescence intensity serving as an indirect measure of cell number. PC12 cells adhered to PL-modified PEG hydrogels at the lower range of acryl-PEG-PL concentrations investigated. Both 'sample' and 'sham' hydrogels displayed statistically significant adhesion (P < 0.0001, ANOVA, Tukey test, power = 0.99) from the negative control (Figs 3 and 4) . At high concentrations of PL (i.e., 1× dilution), substantial cell death was seen as evidenced by EthD-1 staining (data not shown). This is not unusual, as PL is known to be cytotoxic at high concentrations [32] . Although PC12 cell adhesion to the well plate (positive control) was also examined, cell adhesion was not compared with 'sample', 'sham' and negative control hydrogels because it is known that differences in substrate stiffness (i.e., soft hydrogel vs rigid tissue-culture plastic) strongly influence cell morphology and spreading [33] . 
PEG-PCL Hydrogel Coatings
Given these promising initial results with PEG hydrogels, we next investigated response to PEG-hydroxyacid (PEG-HA) hydrogel composites (i.e., PEG-PCL). PEG-HA composites have been previously used as neuro-prosthesis coatings that provide delivery of soluble neurotrophins [6, 8] to enhance neuronal survival, extension and tissue integration. Additionally, in contrast to PEG hydrogels, PEG-HA coatings demonstrate much greater adhesion to hydrophobic electrode array surfaces, which are primarily composed of parylene or polyimide. PEG-HA hydrogels are also degradable through hydrolysis of the ester linkage, thus providing a means of controllably removing the coating after the acute immune response. Given a target of approx. 6-8 weeks for the acute immune response, we investigated slowlydegrading PEG-poly(caprolactone) hydrogels for ability to support PL-conjugation and promote adhesion to neural prosthesis electrode arrays.
Synthesis and Characterization
PEG-PCL polymers were synthesized and characterized by FT-IR and NMR spectroscopy. In the FT-IR spectra for PEG-PCL (Fig. 5A) , notable peaks were observed at 1735 = PCL, COO; 2870 = PEG, CH 2 ; and 3500 cm −1 = PEG, OH. For the diacrylate PEG-PCL, peaks included 1725 = acryl, COO; 1735 = PCL, COO; 2870 = PEG, CH 2 ; and 3550 cm −1 = PEG, OH [6, 34, 35] . The reduction of the OH peak (3550, PEG) confirms the creation of the ester bond between PEG-PCL and acryloyl chloride following the acrylation step. In the 1 H-NMR spectrum for diacrylate PEG-PCL (Fig. 5B) , notable peaks were observed at 3.64 = PEG, CH 2 , 4.08, 4.15, 4.23, 4.31 = PCL, CH 2 (a, position as shown in chemical structure, Fig. 5C ), 1.67 = PCL, CH 2 (b), 2.33 = PCL, CH 2 [35] (c), 5.81, 6.12 and 6.41 ppm = acryl, CH, CH 2 [6, 36] . The average number of CLs per side PEG is approx. 0.967 as calculated using yield of PEG-PCL. The yield for acrylated PEG-PCL co-polymer as calculated from NMR spectra using peak integration was approx. 88.4%. PL-conjugated hydrogels were created using UV-photopolymerization of acryl-PEG-PL segments to the PEG-PCL hydrogel backbone. To confirm conjugation, FITC-PL was used and its fluorescence was observed. As expected, PEG-PCL hydrogels with FITC-PL modification exhibit fluorescence, whereas unmodified PEG-PCL hydrogels do not (Fig. 6). 
PEG-PCL Electrode Adhesion
Adhesion of PEG-PCL hydrogels to an electrode array (retinal prosthesis, Center for Innovative Visual Rehabilitation, Fig. 7 ) was confirmed using insertion-removal and agar blanket tests. The insertion-removal test showed that the hydrogel bolus remains intact and is minimally influenced by the shear force arising from the electrode insertion and removal process (Fig. 8, n = 2) . Further, the agar blanket test showed that PEG-PCL hydrogels can adhere to electrode surfaces for at least 4 weeks (Fig. 9, n = 3) . Degradation of the polymer was observed (evidenced by decreasing surface area occupied by the hydrogel bolus on the electrode surface); however, the rate of degradation was slower when compared with other PEG co-polymers, e.g., poly(ethylene glycol)-poly(lactic acid) [6] , permitting hydrogel adhesion over longer time periods. 
Discussion
Here, we investigated the potential of adhesion molecule-modified PEG-hydrogels to promote neuronal adhesion and thereby improve integration of prosthetic devices with the body. In particular, we examined the effect of polylysine (PL), a non-native biomolecule known to enhance neuronal adhesion. At almost all concentrations of PL investigated, conjugated PL (sample) and sham hydrogels displayed higher and statistically significant PL incorporation from the negative control. This indicates that PL can be both bound to the PEG hydrogel (sample) and physically entrapped within the hydrogel matrix (sample and sham). In either case, only limited diffusion of PL from the hydrogel matrix is observed, indicating the stability of the adhesion molecule-modified neural interface. It should be noted that in the case of the 0.1× acryl-PEG-PL dilution, the PL concentration in the sham was higher, although not statistically significant from that of the negative control. The statistical power of this experiment was 0.93, slightly lower than 0.95 and this difference would most likely have been detected by increasing the sample size, n.
PC12 cells exhibited two behaviors on these surfaces. At low PL concentrations (i.e., 0.01× dilution), PC12 cell adhesion was improved on PL-modified hydrogel surfaces when compared with the negative control. At high PL concentrations (i.e., 1× dilution), cell death was observed (data not shown). This is not unexpected as PL at high concentrations is known to be cytotoxic [32] , resulting in cell lysis. Thus, the potential for PL release to the body will be important to quantify in future in vivo work. PL release from PEGDA gels is limited to desorption of surface bound and lightly entrapped molecules during an initial 5-day period. In this study, all hydrogels were immersed in solution for one week before cell testing to eliminate adsorbed PL. Release from PEGPCL hydrogels would occur as the polymer degraded and is expected to proceed on the order of weeks [27] , a sufficiently slow time-course to prevent high concentrations of PL from being achieved.
In the low PL concentration region, PC12 adhesion on the conjugated sample was higher than that to the unconjugated sham, although not statistically significant; indicating that physically entrapped PL was equally able to support neuronal adhesion. This could be explained through the mechanism of PL-mediated cell adhesion. PL promotes adhesion via the non-receptor mediated cell binding mechanism; i.e., positively charged PL attracts the negatively charged cell membrane resulting from the glycocalyx [21] . It also enhances deposition of serum proteins from medium, thereby indirectly improving cell adhesion. This is in contrast to other adhesion molecules (e.g., laminin, collagen) that promote cell adhesion via ligand-receptor (LR) [21] interactions. In those cases, conjugation of the adhesion molecule to the hydrogel may be necessary to generate traction as the cell pulls on the adhesion molecule. Molecules that are not bound, but only 'entrapped' within the hydrogel, often do not permit the cell to generate the necessary traction force to support adhesion. Additionally, adhesion molecules that employ the LR mechanism primarily promote adhesion through specific sites (e.g., RGD in the case of collagen, IKVAV in the case of laminin [21] ). Steric hindrance of an entrapped molecule can limit access to the adhesion site. Our results suggest that because PL supports adhesion through an alternative mechanism, conjugation may not be required. However, when employing PL, it is important to consider molecular weight as well as PL concentration, as cell response may be altered to PL of varying molecular weight and concentration [32] . It should also be noted that these results may not apply only to neural adhesion, adhesion of other cell types (e.g., astrocytes, microglia) may also be encouraged by PL-modified hydrogels; which will be investigated more fully in future in vivo studies.
We also synthesized degradable PEG-PCL hydrogels and demonstrated PL attachment to these surfaces. The mechanism of PL attachment to this hydrogel is similar to that of PEGDA hydrogels because both hydrogels are formed via photopolymerization. The acryl terminus of acryl-PEG-PL serves as an 'anchor' for PL attachment in both cases. We demonstrated similar PL attachment for both PEGDA and PEG-PCL hydrogels. Additionally, we examined the stability of PEG-PCL hydrogels on neural prostheses surfaces. We showed that PEG-PCL hydrogels can adhere to electrodes for at least 4 weeks, at which point degradation processes become significant. This is an enhancement over previous PEG-PLA hydrogel coatings that adhered for up to 11 days [6] . Long-term adhesion of the polymeric hydrogel is vital for providing sustained biochemical cues that permit neurons to form firm contacts with the electrode array. In addition to adhesion, the hydrogel coating should withstand shear forces arising from the electrode insertion process. This was examined via the insertion test, and the coating evidenced very little difference before and after insertion into an agarose tissue phantom. It is possible that hydrogel adhesion and degradation may be altered by electrical stimulation. Detailed electrical stimulation experiments should yield further insight into this behavior.
Conclusions
PEG-based hydrogels are non-immunogenic, biocompatible and are composed of FDA approved materials. As such, they hold tremendous promise as coatings to enhance biocompatibility of implanted devices. Here, we show that adhesion molecule-modified PEG hydrogels could enhance integration of neural prostheses with target tissue. However, the PL-modified PEG hydrogel system described here is a passive coating that promotes neuron attachment by direct contact and is limited by anatomical considerations and proximity to target tissue. In future work, we hope to combine adhesion molecule presenting hydrogels with soluble factor elution to further enhance tissue-device integration. We have already shown that soluble growth factors can influence neurons distant from the electrode surface [6] and hope to combine this approach with PL-modified hydrogels. Adhesion molecule-modified hydrogels, especially in combination with factor elution, could enhance the neuro-electrode interface and increase efficacy of current neural prostheses.
